Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Bio Farma Urges OIC Countries to Strengthen Vaccine Cooperation

Published: Monday, June 17, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
Bio Farma to make OIC Countries self-reliance in vaccine industry.

Bio Farma has urged Organization of Islamic Cooperation (OIC) member countries to strengthen cooperation in vaccine research to make them self-reliance in vaccine industry.

"We need to strengthen our collaboration in research, production and supply of biological products related to vaccine," Bio Farma President Director Iskandar (one name) said in his presentation in front of vaccine experts attending the 2nd meeting of OIC vaccine & medicine manufacturers, in Bandung, on Sunday.

Prior to Iskandar's presentation on OIC vaccine industry cooperation, delegates from nine OIC member countries (which already have vaccine-making companies or institutions) had approved appointment of Juliman (one name), Bio Farma Director of Production, as chair of the meeting that runs from 16 to 19 June, 2013.

Iskandar emphasized the importance of vaccine research and production among OIC member countries to make them self-reliant in vaccine industry.

He noted the experience of Indonesia, being the world's largest Moslem nation with a population of 240 million, whose need of vaccine has been supplied by the 123-year-old Bio Farma.

For the shorter term period, he said Bio Farma wishes to strengthen the cooperation among Islamic countries in vaccine production while for the medium term it wants to jointly develop new vaccines which are needed by Islamic countries.

Delegates attending the meeting enthusiastically welcomed Indonesia's ideas for an increased cooperation in vaccine research and production to make them self-reliant in vaccine supplies for meeting their needs of vaccine.

Iran and Saudi Arabia, especially, had appreciated Bio Farma's offer for cooperation and initiative on vaccine self-reliance among Islamic countries.

Indonesia's decision to host the meeting is a follow up to the decision of the meeting of Islamic Countries' Advisory Group in Ankara Turkey and the 6th meeting of the OIC Steering Committee on Health in Jakarta.

In addition, the Indonesian government through the letter of the Secretary General of the Ministry of Health to OIC Secretary General has also expressed willingness to host a meeting to finalize the implementation plan for Strategic Health Action Programme 2013-2022.

Bio Farma itself is Indonesia's only vaccine manufacturer whose some of its products have been recognized by the World Health Organization (WHO) so that the company can supply its products to over 100 countries worldwide.

Currently the needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for national immunization program.

Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products. It has also implemented green industry and is environment friendly.

WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.

Bio Farma products are exported to countries around the world through the direct distribution or through various agencies such as UNICEF and PAHO.

The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010, 2011 and 2012 as an evidence of its consistent exceptional performance.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bio Farma Offers Partnerships in Vaccine Development
Company to partner with vaccine manufacturers in developing and Islamic countries.
Monday, October 29, 2012
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
How Cell Growth Triggers Cell Division
Researchers in Jan Skotheim's lab have discovered a previously unknown mechanism that controls how large cells grow, an insight that could one day provide insight into attacking diseases such as cancer.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos